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Abstract
Background: Video capsule enteroscopy (VCE) has revolutionized small bowel imaging, enabling visual
examination of the mucosa of the entire small bowel, while MR enteroclysis (MRE) and CT enteroclysis (CTE) have
largely replaced conventional barium enteroclysis. A new indication for MRE and CTE is the clinical suspicion of
small bowel strictures, as indicated by delayed or non-delivery of a test capsule given before a VCE examination, to
exclude stenosis. The aim of this study was to determine the clinical value of subsequent MRE and CTE in patients
in whom a test capsule did not present itself in due time.
Methods: Seventy-five consecutive patients were identified with a delayed or unnoticed delivery of the test
capsule. Seventy patients consented to participate and underwent MRE (44) or CTE (26). The medical records and
imaging studies were retrospectively reviewed and symptoms, laboratory results and imaging findings recorded.
Results: Lesions compatible with Crohns disease were shown by MRE in 5 patients, by CTE in one and by VCE in
four, one of whom had lesions on MRE. In patients without alarm symptoms and findings (weight loss,
haematochezia, anaemia, nocturnal diarrheoa, ileus, fistula, abscess and abnormal blood tests) imaging studies did
not unveil any such lesion. VCE’s were performed in only 20 patients, mainly younger than 50 years of age,
although no stenotic lesion was shown by MRE and CTE. In the remaining 50 patients no VCE or other endoscopic
intervention was performed indicating that the referring physician was content with the diagnostic information
from MRE or CTE.
Conclusion: The diagnostic value of MRE and CTE is sufficient for clinical management of most patients with
suspected small bowel disease, and thus VCE may be omitted or at least postponed for later usage.
Keywords: Small bowel, enteroclysis, magnetic resonance imaging, computed tomography, patency capsule, video
capsule enteroscopy
Background
The least invasive imaging tool that demonstrates the
mucosa of the whole small bowel in detail is the video
capsule for enteroscopy (VCE). The capsule is an envir-
onmentally friendly, high-tech miniature endoscope,
designed to be swallowed for spontaneous passage
through the small bowel. VCE soon established itself as
a first-line diagnostic procedure of small bowel diseases
[1,2] although it carries a small risk of the capsule get-
ting stuck in a stenosis. In order to avoid this calamity,
a self-disintegrating sham capsule, known as the patency
capsule (PC) and equal in size and shape to the video
capsule, was soon introduced to prove a non-obstructed
small bowel passage. The capsule is naturally excreted
within 18 hours. If not noted, a dedicated screening tool
for external abdominal application is used to trace it. If
the capsule is found to be present or the test is
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equivocal, a radiological examination of the small bowel
is performed to rule out any stenotic lesion before a
diagnostic VCE is contemplated. A retained PC will
spontaneously disintegrate after 36 hours and thus pre-
vent bowel obstruction.
Radiology of the small bowel is today performed as an
enteroclysis, either by means of magnetic resonance
imaging (MRE) or computed tomography (CTE). Both
techniques are established in routine practice [3] and
are highly sensitive for the detection of small bowel
lesions as well as extra-intestinal complications such as
abscesses, fistulae and involvement of other organs
[4-8]. MRE has the advantage of combining high diag-
nostic performance and lack of ionizing radiation and
this is reflected in increasing clinical demand. We
decided to determine the diagnostic outcome of a small
group of patients in whom a PC did not present itself in
due time. These patients all underwent MRE and CTE.
This series is part of our continuous audit of imaging
techniques, diagnostic quality and outcome [9].
Our hypothesis was that after an unnoticed passage of
the PC per rectum or true impaction of the PC, the
diagnostic value of follow-up examination with MRE or
CTE is sufficiently comprehensive for the clinician to
waive or postpone the intended VCE for later use. To
the best of our knowledge, no such information is avail-
able in the literature. Thus, the aim of this study was to
define the clinical value of subsequent MRE and CTE in
patients in whom a test capsule did not present itself in
due time.
Methods
All medical data were dealt with in agreement with the
ethical principles for medical research established in the
Helsinki Declaration of 1975 and as per standard prac-
tice at our department. The study was approved by the
Ethics committee of Lund University and patients gave
their informed consent to let us review their clinical
files and small bowel images for this retrospective
review.
Study design
Consecutive out-patients from the Department of Gas-
troenterology at our University Hospital with clinically
suspected or known disease of the small bowel and who
were referred for VCE, were retrospectively included in
this study. All had an initial PC test that resulted in a
late or unconfirmed excretion of the capsule. These
patients were subsequently examined with either MRE
or CTE. Patient recruitment extended over a three year
period from January 1, 2005, until January 31, 2008,
with follow-up until mid 2010. Of seventy five consecu-
tive patients invited by letter seventy agreed to
participate.
Images were stored on Sectra PACS and reviewed on
a Siemens work station. All appropriate medical records
were reviewed and the following data were recorded:
gender, age at clinical consultation, duration and type of
symptoms (abdominal pain, diarrhoea, weight loss, nau-
sea and anaemia), laboratory analyses (hemoglobin, C-
reactive protein (CRP), leukocytes, orosomucoid and
albumin in serum, and calprotectin in faeces), indication
for the intended VCE, passage delay of PC, and type,
quality and report of imaging studies. Duration of symp-
toms until the time of the PC test, often only given as
an estimate in the medical files, was classified as less
than 1 year, up to 2.5 years and longer than 2.5 years.
The following symptoms and signs were classified as
alarm symptoms: weight loss, haematochaezia, anaemia,
nocturnal diarrhoea, ileus, fistulae and abscesses. When
a VCE had been performed after the PC, its indication
was registered and the VCE based diagnosis was consid-
ered to be the true one. Time between examinations
was calculated.
The diagnostic accuracy of MRE and CTE were calcu-
lated, defining the true diagnosis as the one based on
endoscopic follow-up procedures, or on clinical observa-
tions after the latest imaging procedure for up to 24
months.
Patient characteristics
Seventy patients with a non-documented passage of the
PC, 50 female and 20 male, mean age 45 years, range
10-83 years (Table 1), were included in this series. Five
patients had difficulty in swallowing the PC, and one
patient with neurogenic swallowing dysfunction had the
PC deposited in the duodenum through gastroscopic
deliverance. The clinical indications for the intended
VCE were suspected Crohn’s disease in 47 patients,
small bowel bleeding in 13 patients and abdominal dis-
comfort, mainly related to bowel dysfunction, in 10
patients.
The patient history was less than 12 months in 22
patients, up to 2.5 years in 24 others, and longer in 24




N MRI CT Final VCE
Male Female Male Female Male Female
00-29 22 3 19 - - 2 8
30-49 23 5 12 3 3 4 4
50+ 25 2 3 7 13 2 3
TOTAL 70 10 34 10 16 8 15
N = number of patients, MRI = magnetic resonance imaging, CT = computed
tomography, VCE = video capsule endoscopy.
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patients. The distribution of patients to small bowel
findings of enteroclyses and VCEs is given in Figure 1.
MR and CT enteroclysis
The following technical considerations were valid for
both methods. Patients were allowed free fluid
but otherwise nil by mouth after midnight. After lubri-
cation of the nasal mucosa with 2% lidocaine hydro-
chloride gel (Xylocaine®, AstraZeneca, Gothenburg,
Sweden), a 13 French Gauge naso-jejunal catheter
(insert manufacturer) was advanced under fluoroscopic
guidance beyond the duodeno-jejunal junction. No
conscious sedation was used. Adequate small bowel
luminal distension was achieved by infusing an iso-
osmotic polyethylene glycol solution which is neutral
on CT images (HU = 0), black on T1-weighted MR
images and white on T2-weighted. The infusion rate
was adjusted to 100 ml/min to a total of 1500 +/- 250
ml, and administered via an electric roller pump (Wat-
son Marlow 323®, Wilmington, MA, USA). Lesion
detection was improved by the administration of an
intravenous contrast agent. Scanning commenced
when caecal filling was established and peristalsis
eliminated (20 mg Buscopan® (Boeringer Ingelheim,
Stockholm, Sweden) or 0.3 mg Glucagon® (Novo
Nordic, Malmö, Sweden) intravenously).
MRE
MRI was performed on a 1.5 Tesla MR system (Magne-
tom Symphony, Siemens Medical Solutions, Erlangen,
Germany), using a phased array coil with four elements
being placed on the abdomen. The infusion of the
polyethylene solution was monitored by a heavily
T2-weighted, single-shot turbo spin-echo sequence for
MR fluoroscopy, and motility was studied with coronal
dynamic true fast imaging with steady-state precision
(true FISP) sequence [10]. Small bowel morphology was
examined with a true FISP sequence (TR/TE 6 ms/3 ms,
slice thickness 3 mm) and HASTE images (TR/TE =
infinite/90 ms, slice thickness 5 mm) applied in axial
and coronal planes (image matrix 256 × 256). Following
intravenous application of Gd-DOTA meglumine
(Dotarem®, Guerbet, Aulnay-sous-Bois, France) in a
dose of 0.2 mmol/kg body weight, a coronal 2D gradi-
ent-echo (FLASH) sequence with fat saturation (TR/TE
= 103/7.2 ms, thickness 4 mm, image matrix 256 × 512)
was applied during breath holding [6].
CTE
All patients received an intravenous injection of 120 ml
of iohexol (Omnipaque®, GE Healthcare, Oslo, Norway)
with an iodine concentration of 300 mgJ/ml. The rate of
injection was set at 4 ml/s via an automatic power injec-
tor followed by a saline flush of 50 ml. The volumetric
acquisition was performed in the late arterial dominant
phase, 35 s after the start of injection. CT scanning was
performed on a multi channel detector CT (Somatom
Sensation 16, Siemens Medical Systems, Erlangen, Ger-
many) in prone position, from dome of diaphragm to
pubic symphysis. Scan parameters were 16 × 0.75 mm
collimation with a reconstruction interval of 1.0 mm,
rotation time 0.5 s, tube voltage 100 kV and 240 mAs.
Reformats at 3 mm in transverse, coronal and sagittal
planes were sent to the picture archiving system [11-14].
     70 
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Figure 1 Flow chart of patients and examinations. Figures denote number of patients and gender (male/female). N = normal; abN =
abnormal; 0 = not examined. A final video capsule enteroscopy (VCE) was not considered necessary after magnetic resonance imaging (MRI)-
and computed tomography (CT) enteroclyses in 71% (50/70 patients).
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Evaluation of enteroclysis
All MRE and CTE examinations were re-evaluated by
two radiologists in consensus, one of whom was board-
certified and specialized in gastrointestinal radiology and
endoscopy, and the other in his final training. The over-
all image quality and small bowel distension was defined
as good, sufficient or insufficient separately for the duo-
denum and jejunum, the proximal and mid-ileum, and
the distal and terminal ileum.
The enteroclyses were all re-classified and the follow-
ing features were looked for: bowel wall thickness and
masses, stenotic lesions, pre-stenotic dilatation, regional
contrast enhancement of the mucous membrane and
gut wall as compared to unaffected parts and nearby
vessels, mucosal surface irregularities, mural and trans-
mural involvement, fissures, engorged vessels and fibro-
fatty proliferation of the mesentery and abnormalities of
the peritoneum. Radiologic signs were summarized into
three groups, those compatible with Crohn’s disease, an
alleged bleeding source, i.e. a tumour or an ulcer and
miscellaneous findings such as adhesions, benign adeno-
pathy, impaired peristalsis in an otherwise normal small
bowel and other non-specific observations.
Video capsule enteroscopy (VCE)
The Given Diagnostic Imaging System® (Yoqneam,
Israel) consists of the PillCam SB capsule, which
includes a miniature video camera, an external antenna
with attached portable computer, and a workstation
with appropriate software for review, interpretation, and
reporting of images. The capsule provides two frames
per second over about eight hours, at 1:8 magnification,
with a 140○ field and 1 to 30 mm depth of view. The
capsule is passively progressed through the gastrointest-
inal tract and excreted in the natural way. The patients
fasted overnight before swallowing the capsule. They
were advised to drink liquids after two hours and to
have a light meal after four hours. The patients wore a
belt with a power supply and a small hard drive for
receiving images. Before ingesting the capsule, a sensor
array was fixed to the patient’s abdominal wall and con-
nected to the hard drive. The patients were encouraged
to live as normally as possible during the eight hour
video recording. The equipment was returned to the
Endoscopy Unit the following day and the data down-
loaded to a computer for evaluation. The video record-
ings, featuring more than 50 000 images, were reported
on a workstation. After an evaluation requiring about
one hour, the physician was able to save images and cre-
ate reports to be viewed and printed. The RAPID™
application software also provided a localization diagram
of the capsule’s progress through the small bowel [15].
A PC was used to establish free passage through the
small bowel tract before the proper VCE.
VCE offers a magnified view of the small bowel muco-
sal lining, i.e. tiny capillaries and small clusters of villi
are disclosed in coloured detail. Superficial lesions and
any bleeding source are readily detected. A normal
lumen width is in most instances easy to evaluate,
whereas the reason for a narrowed lumen is more diffi-
cult to determine, be it thickened mucosa, fistulous
opening or an extra-intestinal manifestation, as VCE
cannot reveal any pathologic processes beyond the
mucosa itself [16].
Statistical analyses
Fisher’s exact test was used to calculate associations
between the presence of alarm symptoms, laboratory




The series includes 44 MRE and 26 CTE examinations.
Fluoroscopy of the abdomen before the MRE’s showed
no trace of a retained PC. The quality of radiological
examinations was rated excellent in 64 cases, sufficient
for diagnosis in four (three MRE and one CT examina-
tions) and suboptimal in two female patients, due to
breathing artefacts in one and due to reflux of polyethy-
lene glycol solution into the stomach in the other, leav-
ing too little behind for optimal distension of the
terminal ileum. One female had a second PC prior to a
final VCE, the other was re-evaluated clinically with no
further imaging study requested.
No abnormality was found at MRE and CTE in 60 out
of 70 patients (Figure 1), including all 13 cases of occult
bleeding and nine of 10 cases with abdominal discom-
fort. Signs of Crohn’s disease were revealed in six cases
out of 47 with the same clinical diagnosis. Miscellaneous
findings were revealed in four other cases on MRI
examination where the diagnoses were: adhesions in two
patients after bowel resection for Crohn’s disease,
increased number of normal mesenteric lymph nodes in
one and increased contrast enhancement of normal-
sized, mesenteric lymph nodes in a fourth patient. Both
the latter patients demonstrated normal follow-up
VCEs. Pathologic findings to gender are evident from
table 2.
Video capsule enteroscopy
Twenty-three patients were finally referred for a VCE
examination (Figure 1). The clinical indications were
Crohn’s disease in 15 patients; occult bleeding in five
patients and other indications in three patients. At study
end, no VCE had been carried out in three patients as
two refused the examination and one was cancelled by
the referring clinician. Hence, 20 VCEs were available
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for analysis in 15 of 44 patients previously investigated
with MRI (34%), and five of 26 patients examined with
CT (19%). Half of them were done in young patients up
to 30 years of age. Pathologic findings at VCE were
documented in five females and three males (Table 2).
Out of 15 patients with clinically suspected Crohn’s
disease, final VCE verified the disease in four. Only one
of them had signs of Crohn’s disease on MRI, whilst
three had normal imaging studies. Two of these (one
MRE and another with CTE), had jejunal erosions on
VCE, so far not verified during the follow-up period. On
the MRI examination 14 days earlier an increased num-
ber of normal mesenteric lymph nodes were reported,
but no signs of inflammatory bowel disease and no such
signs at a follow-up ileocolonoscopy examination four
months later. VCE in the third patient, who had under-
gone a CTE, showed minimal changes in the duodenum
and numerous erosions in the terminal ileum. A follow-
up ileocolonoscopy performed two months later
revealed tiny petechiae. Histology of biopsies from the
terminal ileum revealed lymphatic hyperplasia only.
The VCE revealed erosions and mucosal scarring of
NSAID type in one patient, subtle inflammation in the
terminal ileum and a tiny ulcerated polypoid lesion in
another and non-specific mild ileitis with a single small
ulcer in a third patient with normal MRE and ileocolo-
noscopy studies. The last patient had previously under-
gone surgical removal of a duodenal cancer and
presented herself with gastric retention at VCE. In the
five patients with clinically suspected occult bleeding, no
abnormalities were revealed at VCE.
At study end
In 50 of 70 patients (71%) the primarily intended VCE
examination was never performed. Of the 10 patients initi-
ally referred for “abdominal discomfort”, the intended
VCE was not performed in eight. The same was true for
seven of nine patients with an abnormal MRE (Figure 1).
Morphologic signs of abnormality based on one of three
imaging techniques were disclosed in 17 patients, 12
under the age of 50 years, five men and 12 women. Pathol-
ogy was demonstrated by two methods in one male
patient. The mean time between the PC test and entero-
clysis was three months (range 0 - 18 months), between
enteroclysis and final VCE examination 1.5 months, (range
0.5 to four months) in 18 patients, and exceeded 23
months in the last two patients. Seven of 10 patients with
abnormal findings had their examinations soon after their
referral, but this was not statistically significant.
No correlation between alarm symptoms and mor-
phologic findings could be established by any of the
three imaging modalities (data not shown). In contrast,
elevated calprotectin levels in faeces were associated
with an abnormal VCE (p = 0.009), and pathological
laboratory analyses were associated with an abnormal
MRE (p = 0.050). All 17 patients without alarm symp-
toms and with normal laboratory analyses had normal
examinations.
Complications and limitations
The only complication was a non-serious esophageal
contact bleeding after gastroscopic delivery of a PC to
the duodenal cap in one dysphagic patient. One patient
refused VCE because of fear of the capsule getting stuck
and two enteroclyses were technically suboptimal.
Discussion
This study showed that none of the 70 patients referred
for a VCE, who had an undelivered initial PC, had gas-
trointestinal obstruction as proved by follow-up MRE or
CTE examinations. Only 20 of the 70 went on to have a
VCE.
During the three year study period a total of 714
VCEs were performed. Whilst performing a quality
Table 2 Diagnostic results related to gender, age and method of examination











MRI Normal 35 8 27 18 12 5
(n = 44) CD 5 1 4 3 2 -
Misc. 4 1 3 1 3 -
CT Normal 25 9 16 - 5 20
(n = 26) CD 1 1 - - 1 -
VCE Normal 12 4 8 7 4 1
(n = 23) CD 4 1 3 3 1 -
Misc. 4 2 2 - 1 3
Absentee 3 1 2 1 1 1
CD = Crohn’s disease, M = miscellaneous findings (adhesion, stricture, diverticulae, etc.), MRI = magnetic resonance imaging, CT = computed tomography, VCE =
video capsule endoscopy.
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audit we came across a number of patients who had not
gone on to VCE because the preceeding PC did not pre-
sent itself in time. As evident from our results, 60 of 70
consecutive patients with undelivered PC had normal
enteroclysis studies. What happened to these patients
next? What was the clinician’s understanding of our
cross-sectional imaging results, and what impact had
these on patient management? As no such information
was found in the literature, we undertook this retrospec-
tive study to get a qualified estimate of the clinical value
of our imaging performance.
VCE has proven itself to be the most effective exami-
nation in depicting small bowel mucosal lesions, includ-
ing subtle signs of chronic inflammatory diseases [17]
and obscure bleeding [18]. New capsule enteroscopes
designed for oesophageal and colonic exploration are
being introduced to the market [19]. In patients with a
risk of capsule retention (4%), total enteroscopy is still
possible in more than four out of five patients [20,21].
Small bowel neoplasia remains rare but half of them
might be revealed by VCE, i.e. VCE is diagnostically
more efficient than any other imaging modality [22].
The overall diagnostic success with VCE has allowed
gastoenterologists to proclaim VCE to be a first line
procedure in ruling out small bowel disease [23]. How-
ever, the detailed depiction of the inner gut surface with
VCE sometimes gives rise to interpretation difficulties as
the specificity for detecting Crohn’s disease is only 53%
[24]. Accordingly, erosions of the small bowel do not
ultimately lead to a diagnosis of Crohn’s disease [25]. In
the present study we encountered three such cases with
alleged erosions in the terminal ileum, not confirmed at
subsequent ileocolonoscopies.
We were able to make two interesting observations.
One was that no organic lesion was diagnosed by us in
60 cases by MRE and CTE, i.e. the imaging results did
not mirror the clinical suspicion of active small bowel
disease. The other was that in most cases the gastroen-
terologist did not proceed with the primarily intended
VCE examination, neither to confirm imaging results
nor to verify their preliminary clinical suspicion. It was
evident from the medical notes that results of MRE or
CTE, together with a clinical re-evaluation of the
patient’s situation, gave the gastroenterologist sufficient
data not to undertake further enteroscopies.
The reason for the low number of patients diagnosed
with Crohn’s disease with either CTE or MRE in our
series is not known, but has probably to do with image
resolution. Erosions, typical for Crohn’s disease, are
superficial and shallow; viz. lesions limited to the
mucosa are not possible to unveil by these methods.
However, the clinical value of modern enteroclysis
examinations seems to be sufficient as few of the pri-
marily intended VCE examinations were done. The true
clinical value is still pending, but our follow-up of up to
24 months has yet not revealed any new disease, indicat-
ing the absence of false negative imaging studies.
In a patient with a biopsy-proven diagnosis of inflam-
matory bowel disease, future examinations of the bowel
are more focused on complications than on confirma-
tion of diagnosis. In a case like that, cross-sectional ima-
ging with MRE or CTE ought to be performed before
deciding on a VCE, saving the costs for at least a PC.
Furthermore, a strategy that saves a VCE examination,
especially when preceded by a PC, would save health
care costs and minimize inconvenience.
In our department, patients under the age of 45 years
are allocated to MRE, and older ones to CTE. As
Crohn’s disease mostly starts in a younger patient
group, signs of active Crohn’s disease are found more
often with MRI than with CT. A diagnosis of Crohn’s
disease is established when verified endoscopically and
proven by histology [26]. Early diagnosis of is important
as tailored treatment may reverse active disease and pre-
vent complications. Younger patients with symptoms
attributed to the small bowel are likely to harbour early
and superficial lesions, that might be difficult to reveal
on MRE and CTE examinations, but visible on VCE. A
thorough diagnosis is difficult in early disease, mirrored
in our series by the observation that referring doctors
seemed to be more prone to send younger patients to a
final VCE after MRE (15 cases) than after CTE (five
cases). Elective imaging of the small bowel is done as an
enteroclysis procedure in our institution, i.e. with a
naso-jejunal tube, because this allows the radiologist to
achieve optimal bowel filling for maximal diagnostic
performance [10]. Our examination techniques are on a
par with those of leading European experts [6] which
means that our results apply to MRI and CT entero-
clyses and not to MRI or CT enterographies in which
patients are given contrast by mouth.
All patients were selected and referred by gastroen-
terologists from one hospital. The fact that the sample
population consisted of 2.5 times as many females (50/
20) suggests that there might be an imbalance in the
inclusion process of patients with a failed PC test. The
skewed selection may partly be explained by the lim-
ited size of our sample population. Furthermore, it has
been shown that women have longer bowel transit
times than men, which may indicate that the accepta-
ble PC transit time in women ought to be longer than
the 48 h stated [27].
Given the limited size of our material sample, e.g. only
eight cases of established Crohn’s disease, solid statisti-
cal analyses of the temporal aspects of various diagnos-
tic delays were not possible. However, patients
diagnosed with Crohn’s disease had examinations per-
formed closer in time than the others. As might be
Fork et al. BMC Medical Imaging 2012, 12:3
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expected, normality of the imaging studies in patients
with mild to moderate clinical symptoms, i.e. absence of
alarm symptoms, may also be explained by the fact that
many of these patients were admitted to examination
although their laboratory analyses were close to normal.
A limitation of this retrospective study is that not all
patients had a VCE. As only 29% of our patients had a
final VCE we had to accept the clinical follow-up diag-
noses as our “gold standard”. One might comment that
the absence of a final VCE proved our case, viz. gastro-
enterologists did not anticipate any further diagnostic
information of importance for managing 71% of their
patients besides the information obtained by the entero-
clysis examinations.
Conclusion
Based on the observation in our defined group of
patients it seems justified to conclude that the diagnos-
tic value of MRE and CTE studies is sufficient for the
clinical management of patients with alleged small
bowel disease. As a consequence, MRE and CTE entero-
clyses might be chosen as first line examination meth-
ods of the small bowel, followed by VCE’s when
clinically indicated. This might save health care
resources for the better use in other patients. Patients
without alarm symptoms and pathological laboratory
analyses should primarily not be referred to further
examinations.
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